FAYETTE ONCOLOGY ASSOCIATES (EIN 582678171) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

CHARLES FLACH

Phone

4126235781

Tax Period

2024-07-01 to 2025-06-30

FAYETTE ONCOLOGY ASSOCIATES, founded in 2003, is a community nonprofit in the Diseases & Disorders sector that reported $4.6M in total revenue in fiscal year 2024. Revenue grew 8% year-over-year, indicating healthy expansion.

Mission

FAYETTE ONCOLOGY ASSOCIATES PROVIDES OUTPATIENT CLINICAL ONCOLOGY SERVICES TO PATIENTS IN WESTERN PENNSYLVANIA AND THE SURROUNDING TRI-STATE AREAS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $4,626,648

Investment Income $0

Other Revenue $0

TOTAL REVENUE $4,626,648

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,724,346

Fundraising Expenses $0

Program Expenses $4,256,784

Other Expenses $2,900,736

TOTAL EXPENSES $4,625,082

Year-over-Year Comparison

	2024	2023	Change
Revenue	$4,626,648	$4,277,556	+0.1%
Expenses	$4,625,082	$4,277,556	+0.1%
Net Income	$1,566	N/A	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
VINCENT REYES MD	DIRECTOR	1.0	Director	$0	$0	$0
KEVIN ROMBACH R 21425	DIRECTOR	1.0	Director	$0	$0	$0
MAUREEN HATCH R 90624	DIRECTOR	1.0	Director	$0	$0	$0
CARRIE WILLETTS	DIRECTOR & PRESIDENT	1.0	Officer Director	$0	$0	$0
LYNN MATUSIK	DIRECTOR & SECRETARY	1.0	Officer Director	$0	$0	$0
ZIAD DIMACHKIE	DIRECTOR	1.0	Director	$0	$0	$0
CHUCK FLACH J 101024	DIRECTOR & CHAIR	1.0	Officer Director	$0	$0	$0
MARINA ROBERTSON J 50125	DIRECTOR & TREASURER	1.0	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$4,626,648	$4,625,082	$5,093,531	$1,566
2024	$4,277,556	$4,277,556	$4,481,149	No data
2023	$3,580,442	$3,580,442	$3,771,655	No data
2022	$3,437,539	$3,437,539	$3,290,762	No data
2021	$3,551,220	$3,373,918	$3,281,673	$177,302
2020	$3,582,226	$3,582,226	$3,800,785	No data
2019	$3,894,608	$3,894,608	$4,206,240	No data

FAYETTE ONCOLOGY ASSOCIATES